The chemical class known as PDZD11 Inhibitors encompasses a diverse array of compounds that can impact the activity of PDZ Domain Containing 11 (PDZD11). These inhibitors, instead of directly targeting PDZD11, exert their influence through modulation of various signaling pathways and cellular processes that are crucial for PDZD11's functionality. The mechanism of action of these inhibitors involves the alteration of cellular signaling cascades and molecular interactions, which in turn can affect the role of PDZD11 in critical cellular functions such as signal transduction, cell polarity, and membrane trafficking. The pathways targeted by these inhibitors are integral to the regulation of cellular activities, and their modulation can have implications for the activity of PDZD11. This includes the impact on kinase activity, phosphorylation status of proteins, and other cellular signaling mechanisms that are intertwined with PDZD11's functionality.
The role of PDZD11 inhibitors in cellular processes is characterized by their capacity to modify the balance of signaling events within the cell. By influencing pathways such as the PI3K/Akt, MAPK/ERK, mTOR, and various tyrosine kinase pathways, these inhibitors can affect the signaling environment where PDZD11 operates. This includes altering the dynamics of cell signaling, which could influence PDZD11's involvement in these processes. For instance, modulation of the MAPK/ERK pathway can affect signaling cascades where PDZD11 may play a role, while inhibition of kinase pathways like mTOR or PI3K/Akt can have downstream effects on cellular growth and trafficking pathways, impacting PDZD11's function. The inhibitors' interaction with multiple signaling pathways underscores the interconnected nature of cellular signaling and the role of PDZD11 within these networks. The indirect approach of these inhibitors in modulating PDZD11's activity highlights the complexity of cellular regulation and the influence of key regulatory mechanisms within the cell. Such an approach reflects an understanding of the intricate interplay between various molecular pathways and the significance of maintaining the delicate balance within these pathways to ensure proper cellular function and regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Inhibits Protein kinase C and could possibly inhibit PDZD11 by impacting signal transduction pathways where PDZD11 is involved. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits Rho kinase and could possibly inhibit PDZD11 by affecting cell polarity and cytoskeletal organization processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR signaling and could possibly inhibit PDZD11 by influencing cell growth and protein trafficking pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, part of the MAPK pathway, and could possibly inhibit PDZD11 by impacting signaling processes. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
Inhibits the Wnt/β-catenin signaling pathway and could possibly inhibit PDZD11's role in cell signaling. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Blocks calcium channels and could possibly inhibit PDZD11 by affecting intracellular signaling and processes. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibits NF-κB signaling and could possibly inhibit PDZD11 by impacting cellular processes. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β and could possibly inhibit PDZD11 by affecting signaling pathways. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Inhibits EGFR and could possibly inhibit PDZD11 by influencing signaling pathways. | ||||||
AZD4547 | 1035270-39-3 | sc-364421 sc-364421A | 5 mg 10 mg | $198.00 $309.00 | 6 | |
Inhibits FGFR and could possibly inhibit PDZD11 by affecting pathways intersecting with PDZD11's function. | ||||||